SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Oracle Corp. engages in the provision of products and services that address aspects of corporate information technology environments, including applications and infrastructure technologies. It operates through the following business segments: Cloud and License, Hardware, and Services. The Cloud and License segment markets, sells, and delivers enterprise applications and infrastructure technologies through cloud and on-premise deployment models including cloud services and license support offerings. The Hardware segment provides infrastructure technologies including Oracle Engineered Systems, servers, storage, industry-specific hardware, operating systems, virtualization, management, and other hardware-related software. The Services segment offers consulting, advanced support, and education services. The company was founded by Lawrence Joseph Ellison, Robert Nimrod Miner, and Edward A. Oates on June 16, 1977 and is headquartered in Austin, TX.

Oracle Corp.

Oracle shares are experiencing significant volatility and price weakness following their earnings report, with the community largely divided between long-term investors viewing the dip as a buying opportunity and traders attributing the performance to market manipulation. While many participants express frustration over the reversal from pre-market gains despite strong cloud growth and backlog figures, sentiment remains polarized between those anticipating a recovery driven by fundamental strength and those skeptical of the company's capital-intensive AI spending and debt levels.

NuScale Power Corp. provides proprietary and innovative advanced small modular reactor (SMR) nuclear technology, with a mission to help power the global energy transition by delivering safe, scalable, and reliable carbon-free energy. Its products include VOYGR SMR Plants and Energy Exploration (E2) Centers. The company was founded by José N. Reyes in 2007 and is headquartered in Corvallis, OR.

NuScale Power Corporation - Ordinary Shares - Class A

NuScale Power Corp

NuScale Power is experiencing downward pressure following a UBS downgrade to 'Sell' with a reduced price target, as analysts highlight concerns over lengthy construction timelines, cash burn, and the lack of firm customer commitments. While some traders view the decline as a potential buying opportunity given the company's liquidity, others remain skeptical about execution risks and the timeline for commercial project deployment.

Adobe, Inc. is a global technology company, which engages in the provision of digital marketing and media solutions. It operates through the following segments: Digital Media, Digital Experience, and Publishing and Advertising. The Digital Media segment offers products and services that enable individuals, teams, businesses, and enterprises to create, publish, and promote content anywhere and accelerate productivity by transforming view, share, engage with and collaborate on documents and creative content. The Digital Experience segment focuses on integrated platform and set of products, services, and solutions that enable businesses to create, manage, execute, measure, monetize, and optimize customer experiences that span from analytics to commerce. The Publishing and Advertising segment includes legacy products and services that address diverse market opportunities, including eLearning solutions, technical document publishing, web conferencing, document and forms platform, web app development, high-end printing, and Adobe Advertising offerings. The company was founded by Charles M. Geschke and John E. Warnock in December 1982 and is headquartered in San Jose, CA.

Adobe Inc

Adobe shares faced downward pressure as the company named Anil Chakravarthy as its new CEO, a decision that coincided with the departure of another key executive, David Wadhwani. Investors remain divided, with some expressing concern over the leadership transition and growth outlook, while others maintain that the stock remains fundamentally undervalued given its steady financial performance and share buyback programs.

Alliance Entertainment Holding Corp. engages in the distribution of music, movies, and consumer electronics. It distributes its physical media, entertainment products, hardware, and accessories through an established multi-channel strategy. The company was founded in 1990 and is headquartered in Plantation, FL.

Alliance Entertainment Holding Corporation - Ordinary Shares - Class A

Traders are discussing the stock's significant volatility and recent price swings, often attributing the movement to its low float and high insider ownership. While some investors express bullish sentiment regarding the company's fundamentals and collectibles-focused pivot, others remain skeptical, citing concerns over insider selling and previous earnings performance.

Oklo, Inc. engages in the development of fission reactors. It provides clean energy through the design and deployment of fast fission power plants. The company was founded by Jacob DeWitte and Caroline Cochran on July 3, 2013 and is headquartered in Santa Clara, CA.

Oklo Inc. - Ordinary Shares - Class A

Oklo Inc.

Oklo is facing significant selling pressure and volatility following the launch of a new $1 billion at-the-market equity offering program, fueling investor concerns regarding further dilution. While some traders are capitalizing on the dip as a long-term entry point for advanced nuclear infrastructure, others remain critical of the company's lack of commercial revenue and frequent share-sale activity.

Sable Offshore Corp. engages in offshore oil and gas field operations. It focuses on developing the prolific Santa Ynez Unit in federal waters offshore California. The company was founded by James C. Flores on October 16, 2020 and is headquartered in Houston, TX.

Sable Offshore Corp.

Sable Offshore is trending as investors react to the company's recent public offering and convertible notes issuance, which traders view as a necessary step to stabilize finances and secure long-term operations. Community sentiment remains focused on the upcoming legal catalysts involving federal oversight and the Hondo platform restart, with many participants viewing recent price volatility as a potential entry point for a long-term position.

Dell Technologies, Inc. is a technology company, providing customers with a broad and innovative solution portfolio to help customers modernize their information technology (IT) infrastructure, address workforce transformation, and offer critical solutions that keep people and organizations connected. It operates through the following segments: Infrastructure Solutions Group (ISG) and Client Solutions Group (CSG). The ISG segment includes servers, networking, and storage, as well as services and third-party software and peripherals that are closely tied to the sale of ISG hardware. The CSG segment includes designs for commercial and consumer customers of desktops, thin client products, and notebooks. The company was founded by Michael Saul Dell in 1984 and is headquartered in Round Rock, TX.

Dell Technologies Inc - Ordinary Shares - Class C

Dell Technologies Inc

Dell is trending due to significant positive momentum driven by strong AI server demand and favorable analyst initiations, which have helped the stock reach record highs despite debate over recent insider selling and bond offerings. Traders are divided between bullish sentiment regarding the company's AI infrastructure backlog and bearish concerns over potential valuation extremes, volatility, and broader macroeconomic risks.

Fiserv, Inc. engages in the provision of financial services technology. It operates through the Merchant and Financial segments. The Merchant segment offers commerce-enabling products and services including merchant acquiring and digital commerce and mobile payment services, and security and fraud protection, stored-value, and pay-by-bank solutions to companies of all sizes. The Financial segment provides products and services such as processing of customer loan and deposit accounts, digital payments, and card transactions to financial institutions and corporate and public sector clients. The company was founded by Leslie M. Muma and George D. Dalton on July 31, 1984 and is headquartered in Milwaukee, WI.

Fiserv, Inc.

Fiserv is seeing significant volatility as traders debate its long-term potential following recent insider buying and speculation about a potential sale of its debit network, despite persistent concerns over management execution and weak guidance. Community sentiment remains polarized, with some investors viewing the current valuation as a deep-value opportunity while others argue the stock is a "falling knife" facing further downside.

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

The conversation is dominated by frustration and speculation regarding the extended timeline for the 80th death event in the REGAL Phase 3 trial, which has kept the company in a self-imposed quiet period. Traders are actively debating whether this delay, combined with the lack of official updates, signals a successful survival benefit for the treatment arm or suggests underlying issues, while many maintain high conviction in a buyout scenario.

Nu Holdings Ltd. is a holding company, which engages in the provision of digital banking services. The company was founded by David Vélez Osorno, Cristina Helena Zingaretti Junqueira, and Adam Edward Wible on February 26, 2016 and is headquartered in São Paulo, Brazil.

Nu Holdings Ltd - Ordinary Shares Class A

Nu Holdings Ltd

Nu Holdings is seeing increased attention as traders react to a series of positive catalysts, including the company's progress with banking licenses in Mexico and Brazil, successful earnings reports, and analyst reiterations of a Buy rating. While some investors view the current price as an undervalued entry point, others express frustration with recent volatility and the stock's performance relative to broader market growth.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$PHAR Pharming’s Joenja® (leniolisib) has received marketing authorization from the European Commission as the first approved treatment in the EU for activated phosphoinositide 3-kinase delta syndrome (APDS) in adult and pediatric patients aged 12 years and older—an important milestone in Pharming’s strategy to accelerate Joenja® expansion and broaden access for eligible patients with APDS. 
 
The initial launch is expected in Germany in Q3 2026, with additional EU countries to follow as national reimbursement negotiations progress.  
 
Supported by clinical data from the Phase II/III program, the EC authorization marks an important regulatory step for Joenja® in APDS across the EU. 
 
Collectively, these regulatory milestones reflect Pharming’s continued commitment to delivering innovative therapies that help transform the lives of people affected by rare disease communities globally.

StockTwits Web

Pharming Group

 Pharming’s Joenja® (leniolisib) has received marketing authorization from the European Commission as the first approved treatment in the EU for activated phosphoinositide 3-kinase delta syndrome (APDS) in adult and pediatric patients aged 12 years and older—an important milestone in Pharming’s strategy to accelerate Joenja® expansion and broaden access for eligible patients with APDS. 
 
The initial launch is expected in Germany in Q3 2026, with additional EU countries to follow as national reimbursement negotiations progress.  
 
Supported by clinical data from the Phase II/III program, the EC authorization marks an important regulatory step for Joenja® in APDS across the EU. 
 
Collectively, these regulatory milestones reflect Pharming’s continued commitment to delivering innovative therapies that help transform the lives of people affected by rare disease communities globally.

This account has been verified as an official PHAR representative.